Discure Technologies

📍 Herzlyia, Israel👥 7 employees💰 Last funded Mar 2022
Medical Equipment Manufacturing
LinkedIn
The Discure System is designed to treat and reverse degenerative disc disease (DDD), healing the discs, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery. The company received FDA Breakthrough Device Designation, and an award for “Best New Technology in Spine Care in 2021” at the North American Spine Society (NASS) annual meeting, by a panel of KOL spinal surgeons and neurosurgeons. Investors include Rainbow Medical, Johnson & Johnson and multiple venture arms of US-based hospital networks.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Israel
1
Frequently asked questions
Who invested in Discure Technologies?
Discure Technologies has 2 investors on record on gritt.io.
When did Discure Technologies last raise funding?
The most recent investment in Discure Technologies recorded on gritt.io was in March 2022.
What industry is Discure Technologies in?
Discure Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Discure Technologies based?
Discure Technologies is headquartered in Herzlyia, Israel.